Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Pembrolizumab
Related studies linked through entity extraction aliases.
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Pembrolizumab as First-line Treatment for Advanced NSCLC Complicated With COPD
- Status
- UNKNOWN
- Phase
- PHASE2
Efficacy and Safety of Neoadjuvant Pembrolizumab in III-IVA Resectable Oral Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
A Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
SX-682 With Pembrolizumab for the Treatment of Metastatic or Recurrent Stage IIIC or IV Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Pembro With Radiation With or Without Olaparib
- Status
- RECRUITING
- Phase
- PHASE2
CISH Inactivated TILs in the Treatment of NSCLC
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pembrolizumab, Carboplatin and Cabazitaxel in Aggressive Metastatic Castration Resistant Prostate Cancer (PEAPOD_FOS)
- Status
- RECRUITING
- Phase
- PHASE2
A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
BXCL701 and Pembrolizumab in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Induction Immunochemotherapy in Stage III-IVa Head and Neck Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Efficacy and Safety Study of OMTX705, Monotherapy and Anti-PD-1-combined, in Subjects With Advanced Solid Tumors.
- Status
- RECRUITING
- Phase
- PHASE1
Neoadjuvant Pembrolizumab and Lenvatinib for Mucosal Melanoma
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Pembrolizumab Plus CRT Followed by Surgery in Upper ESCC
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2